Search

everythinglearnresearchcommunity

for

Search:↓

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

K6 gene expression can be controlled and manipulated in mice for studying skin disorders.

ITK inhibitors may effectively treat alopecia areata.

IL-15 promotes hair growth and protects hair follicles.

Smad2 and Smad3 are essential for normal skin development, and their absence causes severe skin issues and cancer.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Janus kinase inhibitors are effective and safe for treating alopecia areata.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

Tet2 and Tet3 enzymes are important for controlling hair growth and shape by affecting gene activity and DNA structure in hair follicles.

Stem cells control their future role by changing ERK signal timing, affecting tissue regeneration and cancer.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

Desmosomes are crucial for skin and heart development, and JNK may help regulate them.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

A gene mutation in mice causes skin defects and early death.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

Genetic variations in hair keratin proteins exist but don't significantly affect hair structure.

ERK activation spreads between cells, influencing cell division and wound healing.

Zfp157 is active in many mouse tissues during development and in specific adult cells.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Promising cancer treatments were found, but the manufacturer closed.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.